-
1 Year Later: The ‘Superspreader' Conference That Sparked Boston's COVID Outbreak
One year ago this weekend, more than 100 people from around the world convened at the Boston Marriott Long Wharf hotel for a biotech leadership conference led by the Cambridge-based biotech company Biogen. At the time, the novel coronavirus SARS-CoV-2 was widely known to be circulating. The World Health Organization had already declared the virus and the disease it caused…
-
Biogen Conference in Boston Now Tied to More than 300,000 Coronavirus Cases
A biotech conference held at a Boston hotel in late February that had already been blamed for the initial spread of the coronavirus in eastern Massachusetts has now been tied to hundreds of thousands of cases of the virus globally. The two-day Biogen conference at the Boston Marriott Long Wharf hotel is responsible for infecting as many as 330,000 people…
-
Boston Biogen Conference Outbreak Tied to 300K Coronavirus Cases
More than 300,000 coronavirus cases have been linked to a Biogen leadership conference that was held in February at the Marriott Long Wharf in Boston, according to a new study.
-
FDA Panel Urges Rejection of Experimental Alzheimer's Drug
Government health advisers have sharply criticized an experimental Alzheimer’s drug
-
Mass. Coronavirus Cases See Largest 1-Day Spike Yet, Now at 328
There are now 328 total coronavirus cases in Massachusetts, up 72 from a day earlier. It’s the largest spike since the number of cases jumped from 41 to 92 back on March 10, the same day Gov. Charlie Baker declared a state of emergency. Massachusetts is one of the states in the U.S. with the most coronavirus cases in the…
-
After Coronavirus Outbreak at Biogen Meeting, Company Foundation Commits $10M for Relief
Biogen, the biotech company behind a cluster of coronavirus cases in Massachusetts and several other U.S. states, is committing $10 million to relief efforts in the commonwealth and elsewhere through its foundation. The $10 million the Biogen Foundation is donating “will be used to address immediate critical needs,” mainly in Massachusetts, North Carolina and Italy, for testing, training and health…
-
Mass. Bans Gatherings of More Than 250 People Amid Coronavirus Outbreak
Massachusetts Gov. Charlie Baker on Friday announced announced a ban on gatherings of more than 250 people amid the outbreak of the novel coronavirus. Baker said in a news conference the state had issued guidance prohibiting such gatherings, which include leisure gatherings, faith-based events, sporting events with spectators, concerts, conventions. The order does not apply to normal operations at airports,…
-
Baker Provides Update on State's Coronavirus Preparedness
Massachusetts Gov. Charlie Baker further discussed the state’s coronavirus preparedness on Friday while also announcing a ban on gatherings of more than 250 people.
-
Boston Hotel That Hosted Biogen Meeting Closes Over Coronavirus
The Marriott Long Wharf hotel in Boston was closed indefinitely, days after it was determined that a company’s meeting there was the center of a coronavirus cluster.
-
Boston Hotel That Hosted Coronavirus-Linked Biogen Meeting to Close
The Boston hotel that hosted the Biogen conference at the center of the Massachusetts coronavirus outbreak says it is closing “in the interest of public health.” The hotel said in a statement that the decision to close the Marriott Long Wharf hotel was made in consultation with the Boston Public Health Commission in response to “new information.” There was no…
-
After Spreading Coronavirus, Boston Biogen Meeting Serves as Stark Warning
Seventy-seven of the 95 confirmed cases in Massachusetts have been linked to a meeting of executives with Biogen, a company based in Cambridge, next to Boston, that develops therapies for neurological diseases, state officials said.
-
What We Know About the 70+ Coronavirus Cases Linked to Biogen's Boston Meeting
Ninety-two coronavirus cases have been reported in Massachusetts thus far, and the majority of them have been linked to a conference held by the biotech company Biogen. Here’s everything we know about the conference and the presumptive COVID-19 cases that resulted: Biogen is a 42-year-old biopharmaceutical company that has created treatments for diseases and conditions like Alzheimer’s and multiple...
-
2nd Indiana Resident Has COVID-19 After Traveling to Boston Biogen Meeting
A second person in Indiana has tested positive for COVID-19 after traveling to Boston to attend a biotech firm’s meeting, state officials said Sunday.
-
Coronavirus Test Results Expected Back Saturday, Mass. Hospitals Say
Two Boston hospitals have tested people for COVID-19 coronavirus and are awaiting results, which can be returned within 24 hours, state health officials say.
-
Coronavirus-Linked Biogen Conference Prompts Wave of Testing in Boston
Two Boston hospitals are testing dozens of people who were at a hotel that hosted a conference now linked to several cases of coronavirus. City and state officials spoke about those cases at a briefing, telling the public to stay calm and take steps to protect themselves.
-
3 Who Attended Biogen Meeting in Boston Test Positive for Coronavirus
UPDATE, MARCH 6: Three more people, all Boston residents, who were at the Biogen meeting are presumed to have coronavirus, Mayor Marty Walsh and state health officials said. Details here. Three people who attended a meeting with Biogen employees in Boston last week have tested positive for the coronavirus, the company said Thursday. Following a meeting with Biogen employees in…
-
-
Boston Business Journal Report: Biogen Deviates From Neuroscience Drugs
Life sciences reporter Allison DeAngelis joins necn to discuss her story, “Biogen deviates from neuroscience drugs with $800M acquisition.”
-
Boston Business Journal Report: Biogen Boost Despite Mixed News on Drugs
Life scienes reporter Allison DeAngelis joins necn to discuss her story, “Biogen shares jump despite mixed news on rare disease drugs.”
-
Boston Business Journal Report: Drug Shows Potential to Slow Alzheimer's
Digital editor Max Stendahl joins necn to discuss his story, “Biogen shares leap as Alzheimer’s drug shows potential to slow disease.”